Summary: Qritive has partnered with Roche to integrate its AI-powered cancer diagnostic tools with the Roche navify Digital Pathology platform, enabling more accurate cancer diagnoses.

Takeaways:

  1. Qritive’s AI modules, designed for colon, prostate, breast, and gastric cancers, analyze whole slide images to enhance diagnostic accuracy and reduce pathology reporting times by up to 10-fold.
  2. The integration with Roche navify Digital Pathology platform aims to streamline cancer diagnostics, leading to quicker treatment decisions and better patient outcomes.
  3. This collaboration demonstrates Qritive’s commitment to providing scalable, AI-driven pathology solutions that alleviate healthcare system pressures and improve cancer diagnosis on a global scale.

Qritive, a digital pathology and AI company, announced a collaboration with Roche where it will fully integrate its AI-powered solutions with the Roche navify Digital Pathology platform.

Through this integration, pathologists can leverage AI technology to diagnose cancer more accurately and efficiently, leading to reduced time to treatment and enhanced patient outcomes, according to Qritive. 

Harnessing AI for Digital Pathology

These clinically validated AI modules, designed for colon, prostate, breast, and gastric cancers, analyze whole slide images to identify and grade tumor with precision. These tools have been shown to improve pathology reporting time by up to 10-fold and reduce the risk of misdiagnosis dramatically.

“We are truly excited to see how the integration of our AI-powered solutions within the highly performing Roche navify Digital Pathology platform will augment pathologists’ performance, enabling affordable and accurate diagnostics at scale,” says Bruno Occhipinti, CEO of Qritive.

Qritive and Roche Collaboration

Qritive’s collaboration with Roche reinforces its commitment to empowering pathologists globally with state-of-the-art AI-powered solutions and alleviating the pressure on the healthcare system, the company says. By bringing its innovative AI-based pathology solutions to a broader audience, Qritive continues to play a pivotal role in the future of cancer diagnostics.

Further reading: Roche Collaborates with PathAI to Expand Digital Pathology Capabilities for CDx

Featured image: Qritive’s QAi Prostate Grade algorithm integrated with Roche navify digital pathology platform. Photo: Qritive